CAH
60
2
DD
61
4
IP
70
-3
DFS
67
-3
MLM
57
-3
SYY
47
-2
NRG
50
-2
SCHW
65
-2
XRX
34
-3
CF
53
2
EFX
41
-2
ADM
24
2
AMG
43
3
TXN
49
-6
NWS
79
-4
CHRW
67
3
MU
32
-6
IVZ
49
-3
BK
72
-2
XEL
65
-2
CAH
60
2
DD
61
4
IP
70
-3
DFS
67
-3
MLM
57
-3
SYY
47
-2
NRG
50
-2
SCHW
65
-2
XRX
34
-3
CF
53
2
EFX
41
-2
ADM
24
2
AMG
43
3
TXN
49
-6
NWS
79
-4
CHRW
67
3
MU
32
-6
IVZ
49
-3
BK
72
-2
XEL
65
-2
Financhill
Back

BioLife Solutions 10K Form

Buy
58

BLFS
BioLife Solutions

Last Price:
21.82
Seasonality Move:
6.14%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-10 10Q BLFS/BioLife Solutions Quarterly
2023-11-09 10Q BLFS/BioLife Solutions Quarterly
2023-08-09 10Q BLFS/BioLife Solutions Quarterly
2023-05-11 10Q BLFS/BioLife Solutions Quarterly
2022-11-09 10Q BLFS/BioLife Solutions Quarterly
2022-08-09 10Q BLFS/BioLife Solutions Quarterly

Receive BLFS News And Ratings

See the #1 stock for the next 7 days that we like better than BLFS

BLFS Financial Statistics

Sales & Book Value

Annual Sales: $143.27M
Cash Flow: $5.46M
Price / Cash Flow: 0
Annual Sales: $6.97
Price / Book: 3.8

Profitability

EPS (TTM): -1.64000
Net Income (TTM): $-73.45M
Gross Margin: $46.75M
Return on Equity: -21.91%
Return on Assets: -18.06%

BioLife Solutions Earnings Forecast

Key BioLife Solutions Financial Ratios

  • The Gross Profit Margin over the past 35 years for BLFS is 32.63%.
  • The Selling, General & Administrative Expenses for BLFS have been equal to 56.05% of Gross Profit Margin.
  • The Research & Development expenses have been 13.12% of Revenue.
  • The Interest Expense is -0.49% of Operating Income.
  • The Net Earning history of BLFS is -46.36% of Total Revenues.
  • Per Share Earnings over the last 35 years have been positive in 15 years.

BioLife Solutions Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: BLFS
CUSIP: 09062W
Website: biolifesolutions.com

Debt

Debt-to-Equity Ratio: 0.07
Current Ratio: 2.86
Quick Ratio: 1.69

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BLFS Technical Analysis vs Fundamental Analysis

Buy
58
BioLife Solutions (BLFS) is a Buy

Is BioLife Solutions a Buy or a Sell?

  • BioLife Solutions stock is rated a Buy
    The current BioLife Solutions [BLFS] share price is $24.11. The Score for BLFS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.